Camden Biotechnology began operations in September 2016. The following selected transactions relate to liabilities of the company for September 2016 through March 2017. Camden's fiscal year ends on December 31. Its financial statements are issued in April. 2016 a. On September 5, opened checking accounts at Second Commercial Bank and negotiated a short-term b. On October 1, borrowed $18 million cash from Second Commercial Bank under the line of credit and Received $2,800 of refundable deposits in December for reusable containers used to transport and line of credit of up to $21,000,000 at the bank's prime rate (9.5% at the time). The company will pay no commitment fees issued a five-month promissory note. Interest at the prime rate of 9% was payable at maturity. Management planned to issue 10-year bonds in February to repay the note. c. store chemical-based products. d. For the September-December period, sales on account totaled $4,340,000. The state sales tax rate is 3% and the local sales tax rate is 3%-(This is a summary journal entry for the many individual sales transactions for the period.) e. Recorded the adjusting entry for accrued interest 2017 f. In February, issued $17 million of 10-year bonds at face value and paid the bank loan on the March 1 due date g. Haif of the storage containers covered by refundable deposits were returned in March. The remaining containers are expected to be returned during the next six months. Required 1. Prepare the appropriate journal entries for 2016 and 2017 transactions. (If no entry is required for a transaction/event, select "No journal entry required".in the first account field. Enter your answers in whole dollars.) View list view journal entry worksheet No Transaction General Journal Debit Credit No journal entry required 18,000,000 Notes payable 18,000,000 6 MacBook Air F2 F5